Parp-1 deficiency causes an increase of deletion mutations and insertions/rearrangements in vivo after treatment with an alkylating agent.

Source:http://linkedlifedata.com/resource/pubmed/id/15608683

Oncogene 2005 Feb 17 24 8 1328-37

Download in:

View as

General Info

PMID
15608683